# Hikma Pharmaceuticals

Source: https://onco.cc/companies/hikma/  
OnCo record `hikma` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Hikma is one of the largest makers of generic sterile injectables for US hospitals, including many chemotherapy and supportive-care drugs, from plants in Ohio, New Jersey and Portugal.

## Summary

Hikma Pharmaceuticals, founded in Amman in 1978 and listed in London, supplies hundreds of injectable generics to hospitals in the United States and elsewhere, among them oncology drugs and the antiemetics, steroids and anti-infectives given alongside them. Its injectables plants in Columbus, Ohio, Cherry Hill, New Jersey, and Portugal are the kind of sterile capacity that determines whether a shortage of a low-margin cancer drug can be filled by a second supplier.

## Fields

- Kind: Company
- Last checked: 2026-09-17
- Tags: manufacturing-wave
- HQ: London
- Type: pharma
- Website: https://www.hikma.com
- Ticker: HIK

## Sources

- Official website: https://www.hikma.com

## Connected records

- technologies: [Generic oncology drug supply and shortage mitigation](https://onco.cc/technologies/generic-drug-shortage-response/), [Generic sterile injectables (the 2023 platinum shortage)](https://onco.cc/technologies/sterile-injectable-generics-manufacturing/), [Sterile fill-finish and lyophilisation](https://onco.cc/technologies/sterile-fill-finish/)
- drugs: [Dexamethasone](https://onco.cc/drugs/dexamethasone/), [Ondansetron](https://onco.cc/drugs/ondansetron/)

---
JSON: https://onco.cc/api/v1/entities/hikma.json